Based on its potent capacity to induce tumor cell death and to abrogate clonogenic survival,
radiotherapy is a key part of multimodal cancer treatment approaches. Numerous clinical …

Radionuclide therapy utilizes unsealed sources of radionuclides as a treatment for cancer or
other pathological conditions such as rheumatoid arthritis. Radionuclides that decay by the …

One Radiobiopharmaceutics.-1 Preparation of radiopharmaceuticals.-Production of
radionuclides.-Synthesis of the non-radioactive compound.-Reaction of the radionuclide …

Radionuclide therapy is a promising modality for treatment of tumours of haematopoietic
origin while the success for treatment of solid tumours so far has been limited. The authors …

The National Cancer Institute's (NCI) Radiation Research Program (RRP) is endeavoring to
increase the relevance of preclinical research to improve outcomes of radiation therapy for …

In the past decade, and pointing onwards to the immediate future, clinical radiotherapy has
undergone considerable developments, essentially including technological advances to …

The potential use of radionuclides in therapy has been recognized for many decades. A
number of radionuclides, such as iodine-131 (131 I), phosphorous-32 (32 P), strontium-90 …

Targeted radionuclide therapy is one of the most intensively developing directions of nuclear
medicine. Unlike conventional external beam therapy, the targeted radionuclide therapy …

The use of radionuclides in medicine is based largely on the discoveries of two critical
concepts, the “tracer principle” and the “magic bullet”. In 1913, George de Hevesy …

Targeted radionuclide therapy (TRT) is a branch of cancer medicine concerned with the use
of radioisotopes, radiolabelled molecules, nanoparticles, or microparticles that either …